s6y

Propanc Biopharma, Inc.

Ticker
PPCB
CIK
1517681
Industry
Pharmaceutical Preparations
Formerly
Propanc Health Group Corp

Financials 75

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-K Annual Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-Q Quarterly Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-K Annual Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-Q Quarterly Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-K Annual Report for period ending Jun 30, 2024

All 75 financials filings

News 131

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 131 news filings

Ownership 20

  1. 4 Statement of changes in beneficial ownership of securities
  2. SC 13G Major Shareholders
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. SC 13G Major Shareholders
  7. SC 13G Major Shareholders
  8. 3 Initial statement of beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 20 ownership filings

Prospectus 72

  1. S-1 General form of registration statement for all companies including face-amount certificate companies
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. S-1 General form of registration statement for all companies including face-amount certificate companies
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-1/A General form of registration statement for all companies including face-amount certificate companies
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. S-1 General form of registration statement for all companies including face-amount certificate companies
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. 424B4 Prospectus filed pursuant to Rule 424(b)(4)

All 72 prospectus filings

Proxies 32

  1. DEF 14C Definitive information statements
  2. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  3. DEF 14C Definitive information statements
  4. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  5. DEF 14C Definitive information statements
  6. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEF 14C Definitive information statements
  9. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  10. DEF 14C Definitive information statements

All 32 proxies filings

Other 109

  1. EFFECT Notice of Effectiveness
  2. EFFECT Notice of Effectiveness
  3. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  4. UPLOAD Letter (PDF)
  5. EFFECT Notice of Effectiveness
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. UPLOAD Letter (PDF)
  10. EFFECT Notice of Effectiveness

All 109 other filings